Our Platform
Designing the molecules of tomorrow
demands a ‘predict-first’ approach
The leading computational platform for molecular discovery and design
Accelerating the convergence of physics, machine learning and enterprise informatics
Built upon more than 30 years of R&D, our industry-leading computational platform is transforming the way therapeutics and materials are discovered by enabling highly accurate in silico predictions of key molecular properties across vast chemical space.
Life Science
High-precision design of novel therapeutics through exploration of vast chemical space and accurate prediction of key properties of molecules
The industry-leading software platform for discovery and optimization of molecules for today’s biotech and pharmaceutical innovators
A pipeline of collaborative and proprietary drug discovery programs, powered by our platform
Materials Science
Design higher-performing, more sustainable materials while accelerating development timelines and gaining an improved understanding of development processes.
A tireless commitment to scientific advances
The power of our platform lies in a continuous feedback loop. We invest heavily in the science underlying our technology, and we use our platform internally to advance a pipeline of proprietary and collaborative therapeutics.
The insights we gain are fed back into the software, further refining its predictive capabilities and expanding the breadth of applications it supports. This ongoing innovation is delivered back to our users through regular software updates.
Case Study
Life Science
Case Study
Materials Science
Webinar
Life Science
Design of a Highly Selective, Allosteric, Picomolar TYK2 Inhibitor in Clinical Development
In this webinar, we will highlight key moments from the discovery of this potentially best-in-class selective, allosteric, picomolar inhibitor of TYK2.